iProtics

Private

LeidenHealthcare & Life Scienceshttps://iprotics.eu/

Last Round

Seed

Oct 10, 2024

Total Funding Raised

$850,000

Company Overview

iProtics is a biotechnology company developing selective immunoproteasome inhibitors to treat hematological cancers and autoimmune disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

immunoproteasome inhibitorpeptide-based therapydrug discoveryhematological cancerautoimmune disorderbiotech startuppre-clinical developmenttargeted therapyoncology researchbiotech spin-outproteasome inhibitorprecision medicinedrug pipelinebiopharma

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

iProtics Comparables

Compare iProtics with similar companies based on industry and business-model similarity.

iProtics comparables — related companies by embedding similarity
Company	Similarity	Market Cap
IpiNovyx Bio	87%
QLi5 Therapeutics GmbH	82%
Aurinia Pharmaceuticals Inc.	76%

View all Comparables

iProtics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Oct 10, 2024
Grant	Mar 20, 2024
Accelerator	Sep 9, 2022

View all Funding Rounds

Key People

Founding team and executive leadership

Elmer Maurits

CEO Co-founder

Founding Team

iProtics Investors

Notable investors and investment history

iProtics investors
Investor	Rounds
Libertatis Ergo Holding	Seed
Netherlands Organization for Scientific Research	Grant
Life Sciences @ Work Venture Challenge	Accelerator

View all Investors

iProtics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

iProtics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about iProtics's valuation, stock price, and market status.

Firmographic Details

HeadquartersLeiden

Employee Range2

Year Founded2024

Last FundingOct 10, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.